11-2270166-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_005170.3(ASCL2):c.167A>G(p.Asn56Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 1,519,068 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005170.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151900Hom.: 0 Cov.: 34
GnomAD4 exome AF: 0.0000132 AC: 18AN: 1367168Hom.: 0 Cov.: 34 AF XY: 0.0000103 AC XY: 7AN XY: 676678
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151900Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74214
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.167A>G (p.N56S) alteration is located in exon 1 (coding exon 1) of the ASCL2 gene. This alteration results from a A to G substitution at nucleotide position 167, causing the asparagine (N) at amino acid position 56 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at